Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1955 Dec;34(12):1730–1737. doi: 10.1172/JCI103227

GLUCAGON-INDUCED HYPERGLYCEMIA AS AN INDEX OF LIVER FUNCTION 1,2

Theodore B Van Itallie 1,3, William B A Bentley 1
PMCID: PMC438755  PMID: 13271557

Full text

PDF
1730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMATUZIO D. S., SCHULTZ A. L., VANDERBILT M. J., RAMES E. D., NESBITT S. The effect of epinephrine, insulin, and hyperthyroidism on the rapid intravenous glucose tolerance test. J Clin Invest. 1954 Jan;33(1):97–102. doi: 10.1172/JCI102876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DRURY D. R., WICK A. N., SHERRILL J. W. The effect of the hyperglycemic factor on the metabolism of glucose by the extrahepatic tissues. Diabetes. 1954 Mar-Apr;3(2):129–132. doi: 10.2337/diab.3.2.129. [DOI] [PubMed] [Google Scholar]
  3. INGLE D. J., NEZAMIS J. E., HUMPHREY L. M. Absence of hyperglycemic effect of glucagon in the eviscerate rat. Proc Soc Exp Biol Med. 1953 Oct;84(1):232–233. doi: 10.3181/00379727-84-20600. [DOI] [PubMed] [Google Scholar]
  4. INGLE D. J., NEZAMIS J. E. The effect of epinephrine upon the glucose tolerance and work performance of the eviscerate rat. Endocrinology. 1950 Jan;46(1):14–20. doi: 10.1210/endo-46-1-14. [DOI] [PubMed] [Google Scholar]
  5. KIRTLEY W. R., WAIFE S. O., HELMER O. M., PECK F. B. Effect of purified glucagon (hyperglycemic-glycogenolytic factor, HGF) on carbohydrate and corticoid metabolism in normal and diabetic subjects. Diabetes. 1953 Sep-Oct;2(5):345–349. doi: 10.2337/diab.2.5.345. [DOI] [PubMed] [Google Scholar]
  6. Loeb R. F., Reeves E. B., Glasier H. P. RESPONSES TO THE INJECTION OF EPINEPHRINE IN HEPATIC DISEASE. J Clin Invest. 1931 Apr;10(1):19–31. doi: 10.1172/JCI100339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MANN J. D., WAKIM K. G., BAGGENSTOSS A. H. The vasculature of the human; a study by the injection-cast method. Proc Staff Meet Mayo Clin. 1953 Apr 22;28(8):227–232. [PubMed] [Google Scholar]
  8. ROOT M. A., ELLIS J., STAUB A. Effect of glucagon on insulin hypoglycemia. Proc Soc Exp Biol Med. 1954 Mar;85(3):507–511. doi: 10.3181/00379727-85-20934. [DOI] [PubMed] [Google Scholar]
  9. SOMOGYI M. Studies of arteriovenous differences in blood sugar. V. Effect of epinephrine on the rate of glucose assimilation. J Biol Chem. 1950 Oct;186(2):513–526. [PubMed] [Google Scholar]
  10. STAUB A., SINN L., BEHRENS O. K. Purification and crystallization of hyperglycemic glycogenolytic factor (HGF). Science. 1953 Jun 5;117(3049):628–629. doi: 10.1126/science.117.3049.628. [DOI] [PubMed] [Google Scholar]
  11. SUTHERLAND E. W., CORI C. F. Effect of hyperglycemic-glycogenolytic factor and epinephrine on liver phosphorylase. J Biol Chem. 1951 Feb;188(2):531–543. [PubMed] [Google Scholar]
  12. SUTHERLAND E. W. The effect of the hyperglycemic factor and epinephrine on enzyme systems of liver and muscle. Ann N Y Acad Sci. 1951 Dec;54(4):693–706. doi: 10.1111/j.1749-6632.1951.tb46623.x. [DOI] [PubMed] [Google Scholar]
  13. VAN ITALLIE T. B., MORGAN M. C., DOTTI L. B. Effect of glucagon on peripheral utilization of glucose in man. J Clin Endocrinol Metab. 1955 Jan;15(1):28–35. doi: 10.1210/jcem-15-1-28. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES